Impact of Cyclin-dependent Kinase Inhibitor 1A Genotypes on Prostate Cancer Susceptibility Prediction
While <i>CDKN1A</i> rs1801270 and rs1059234 may not serve as general predictive markers for prostate cancer susceptibility, they appear to modulate prostate cancer risk under specific age and smoking contexts. These findings merit further validation in larger and ethnically diverse populations and may contribute to more refined risk stratification and personalized prevention strategies.
Authors
- Wen‐Chin Huang (ORCID: https://orcid.org/0000-0003-2342-9099)
- YUN-CHI WANG
- Chia-Wen Tsai (ORCID: https://orcid.org/0000-0002-8324-6596)
- Jaw‐Chyun Chen (ORCID: https://orcid.org/0000-0001-8468-5702)
- Te‐Chun Hsia (ORCID: https://orcid.org/0000-0003-4297-9918)
- Boren Wang
- Shu-Yu Chang
- Cheng-Hsi Liao
- HOU-YU SHIH
- WEN-SHIN CHANG (ORCID: https://orcid.org/0000-0003-1735-2857)
- DA-TIAN BAU
- Hsu-Tung Lee
Institutions
- China Medical University (TW)
- Taichung Armed Forces General Hospital (TW)
Publication Details
- Journal
- In Vivo
- Published
- 2025-10-29
- DOI
- https://doi.org/10.21873/invivo.14118
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00